Tennis World Faces Doping Scandals: Vondrousova Ban Follows Cases of Sharapova, Hingis

The world of professional tennis is once again grappling with doping violations, with the recent four-year suspension of former world No. 6 and 2023 Wimbledon champion Marketa Vondrousova for refusing a doping test in December 2025. This incident brings to the forefront the strict anti-doping regulations in place and the severe penalties for non-compliance.

The article details several other significant doping cases that have marked the 21st century in tennis. Argentine player Mariano Puerta faced an eight-year ban, later reduced, after testing positive for an anabolic steroid in 2003 and then for a stimulant in 2005, the latter occurring after he reached the French Open final against Rafael Nadal.

Swiss star Martina Hingis, a former world No. 1, retired for the second time in 2007 after testing positive for cocaine at Wimbledon. Despite maintaining her innocence, she received a two-year suspension. Croatian player Marin Cilic also faced a suspension in 2013 for a stimulant, though his ban was later reduced to four months by the Court of Arbitration for Sport (CAS) after he successfully argued for an involuntary ingestion.

Russian icon Maria Sharapova received a two-year ban in 2016 after traces of meldonium were found in her system. The suspension was reduced to 15 months by the CAS. More recently, Romanian player Simona Halep, a two-time Grand Slam champion, had her career halted by a doping suspension.